BIOMAT Database Logo BIOMAT Database Logo

[Betamethasone-17-valerate for topical use in dermatologic therapy]. 1965

M Avellino

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm

Related Publications

M Avellino
[TOPICAL USE OF BETAMETHASONE 17-VALERATE].
November 1964, Alergia,
M Avellino
[Study of a new corticosteroid for dermatologic use: betamethasone 17-valerate].
May 1965, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M Avellino
BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
May 1964, Lancet (London, England),
M Avellino
[Clinical experimentation of a new preparation: "betamethasone-17-valerate" for topical use].
August 1965, Minerva dermatologica,
M Avellino
[Dermatologic clinical study of betamethasone 17-valerate applied locally].
January 1967, Archives belges de dermatologie et de syphiligraphie,
M Avellino
Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.
November 1967, Lancet (London, England),
M Avellino
Betamethasone 17-valerate. A custom-made topical corticosteroid.
May 1967, Archives of dermatology,
M Avellino
[Clinical use of betamethasone 17-valerate].
August 1966, Hifuka kiyo. Acta dermatologica,
M Avellino
Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
January 1993, The British journal of dermatology,
M Avellino
[Betamethasone valerate, a new corticoid for topical use in dermatology].
June 1965, Prensa medica argentina,
Copied contents to your clipboard!